HCPCS Level IIprocedureActive
G9078
Onc dx prostate t2no progres
BETOS: P7B
Effective: 2007-01-01
Description
Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t2 or t3a gleason 8-10 or psa > 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
Medicare Fee Schedule
2026 Medicare Physician Fee Schedule national payment rates
$0.00
Non-Facility Price
$0.00
Facility Price
0.00
Work RVU
0.00
Total RVU (Non-Fac)
XXX
Global Days